IFNA2 and COVID-19: The low transcriptional levels of IFNA2 detected in blood are consistent with decreased numbers of circulating plasmacytoid DCs (pDCs) and impaired production of type I IFN by circulating pDCs in COVID-19 patients reported by others (10, 16, 19).